PUBLIC COMPANY
save$XERSXeris Biopharma Holdings, Inc.
$XERS8.5200-0.93%Chicago, IL, USupdated 12h ago
community read0 votes
pipeline
3
marketed
2
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Phase 22Marketed
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D
- phase2Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
- phase2Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Mar 12, 26option exerciseMcCulloch Kevin · See Remarks48,894 sh
- Mar 12, 26option exerciseMcCulloch Kevin · See Remarks48,894 sh
- Mar 12, 26option exerciseMcCulloch Kevin · See Remarks4 sh
- Mar 12, 26option exerciseMcCulloch Kevin · See Remarks4 sh
- Mar 5, 26option exercisePieper Steven · See Remarks27,891 sh
- Mar 5, 26option exercisePieper Steven · See Remarks14,036 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that